ARWR

ARWR

USD

Arrowhead Pharmaceuticals Inc. Common Stock

$37.850-0.750 (-1.943%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$38.600

Haut

$39.310

Bas

$37.770

Volume

1.40M

Fondamentaux de l'Entreprise

Capitalisation Boursière

5.2B

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

2.39M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $9.57Actuel $37.850Haut $43.69

Actualités Connexes

BusinessWire

Arrowhead Pharmaceuticals to Participate in Upcoming November 2025 Conferences

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that it is scheduled to participate in the following upcoming events: American Heart Association (AHA) Scientific Sessions 2025 – November 7-10,

Voir plus
Arrowhead Pharmaceuticals to Participate in Upcoming November 2025 Conferences
BusinessWire

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that as an inducement to entering into employment with the Company, on October 24, 2025, the Company's Board of Directors approved "inducement" grants to 84

Voir plus
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
BusinessWire

Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Novartis

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that a global licensing and collaboration agreement with Novartis, previously announced on September 2, 2025, has now closed. Closing of the transaction was

Voir plus
Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Novartis

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.